Skip to main content
. Author manuscript; available in PMC: 2022 Feb 1.
Published in final edited form as: J Mol Cell Cardiol. 2020 Nov 12;151:46–55. doi: 10.1016/j.yjmcc.2020.11.002

Figure 5. CORO6 mRNA contains a conserved m6A peak in non-failing human and control rat samples.

Figure 5.

(A) General schematic for m6A peak comparison between human non-failing and neonatal rat control cardiomyocytes samples. (B) Venn diagram of transcripts containing enriched m6A peaks in non-failing (dark gray) and rat cardiomyocytes control (light gray) (FC >1.5 by exomePeak). Comparison found 11 total transcripts to be co-enriched. (C) Table outlining 11 transcripts co-enriched in non-failing and isolated rat cardiomyocytes control samples. Genes in bold have conserved m6A peaks at the nucleotide level. (D) Gene view of CORO6, which contains a conserved m6A peak enriched in both human non-failing (top, dark gray) and rat control (bottom, light gray) samples when compared to failing (red) or hypertrophic (blue) samples, respectively. The enriched peak calculated by exomePeak (green) is shown in relation to the total gene (left) and in relation to the specific exon (right). Read counts are found bracketed (top right, black).